What is Emergent Biosolutions's EV / sales?

Emergent Biosolutions (EBS) reported EV / sales of 1.3× in Q1 2026.

How has Emergent Biosolutions's EV / sales changed year-over-year?

Emergent Biosolutions's EV / sales increased by 55.0% year-over-year, from 0.8× to 1.3×.

What is the long-term trend for Emergent Biosolutions's EV / sales?

Over 5 years (2020 to 2025), Emergent Biosolutions's EV / sales has grown at a -15.9% compound annual growth rate (CAGR), from 3.3× to 1.4×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Emergent Biosolutions EBS EV / sales

EV / sales at other companies

Thermo Fisher ScientificTMO

5.1×-0.9×

Regeneron PharmaceuticalsREGN

5.5×+0.6×

AMP

Amphastar PharmaceuticalsAMPH

1.9×-0.6×

Amneal Pharmaceuticals, Inc.AMRX

2.1×+0.4×

CorMedixCRMD

2.5×-7.9×

Collegium Pharmaceutical, Inc.COLL

1×-0.3×

Other financials

Income statement

See full

Revenue$156.1M-29.7%

Gross profit$84.1M-37.1%

Operating income$10.5M-79.0%

Net income$6.8M-90.0%

EPS (diluted)$0.07-94.1%

Balance sheet

See full

Cash & equivalents$161.5M+5.7%

Total debt$584.6M-13.1%

Total equity$523.1M-5.4%

Total assets$1.3B-7.4%

Cash flow

See full

Operating cash flow-$33.8M-202%

CapEx$2.4M-33.3%

Free cash flow-$36.2M-145%

Valuation

See full

Market cap$411.74M+22.0%

Enterprise value$834.84M-2.6%

P/E3.6×—

P/S0.6×+0.3×

Profitability

See full

Gross margin54.2%+19.0pp

Operating margin15%+10.3pp

Net margin9.6%+5.8pp

FCF margin20.8%—

Returns & leverage

See full

Return on equity13.9%+8.1pp

Debt / equity1.1×-0.1×

Current ratio4.3×-2.0×

Where this comes from

Calculated from Emergent Biosolutions’s reported figures.

enterprise value/total revenue=1.3×

Based on the most recent quarter.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Emergent Biosolutions's EV / sales?: Emergent Biosolutions (EBS) reported EV / sales of 1.3× in Q1 2026.
How has Emergent Biosolutions's EV / sales changed year-over-year?: Emergent Biosolutions's EV / sales increased by 55.0% year-over-year, from 0.8× to 1.3×.
What is the long-term trend for Emergent Biosolutions's EV / sales?: Over 5 years (2020 to 2025), Emergent Biosolutions's EV / sales has grown at a -15.9% compound annual growth rate (CAGR), from 3.3× to 1.4×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.